GENE ONLINE|News &
Opinion
Blog

Partner
Rob Knight and Jing-Yuan Fu Elaborate On Microbiome Research Trends at the 7th Asia Microbiome Conference(AMC)
2023-01-17Partner
RemeGen Presented New Data Updates on Telitacicept for SLE and primary Sjogren’s syndrome at ACR Convergence 2022
2022-12-05Partner
Micronbrane Medical Aspires to Further Clinical Collaboration Following the Successful Series A Funding
2022-12-01Partner
Moving Past Animal Models with Better Data for Drug Discovery
2022-11-23Partner
Illumina Genomics Forum Highlights – President Obama, Novel Sequencer, Bill Gates
2022-11-17Partner
RemeGen Looks to Take Next Global Steps During ASN Kidney Week 2022
2022-11-15Partner
RemeGen Biosciences to Present New Data Updates in ACR 2022
2022-11-11Partner
Coastar Therapeutics Receives Venture Capital Investment to Further Develop Delivery Technology of Biologics for Cancer and Gene Therapies
2022-11-10Partner
RemeGen Biosciences to Attend ASN Kidney Week 2022
2022-11-03Partner
Caliway Biopharmaceutical Announces Achievements in Revolutionary Fat Reduction Therapy
2022-08-02Partner
Reinvigorating the Asian Biomedical Ecosystem With BIO Asia-Taiwan 2022
2022-07-26Partner
Taiwan’s Biotech Industry Shines at the 2022 BIO International Convention
2022-06-24Partner
BIO Asia-Taiwan 2022: Connecting the Asian Value Chain
2022-06-14Partner
Over 50 Taiwan Organizations to Present at 2022 BIO International Convention
2022-06-08Partner
CYTENA BPS and Leadgene Bio to Level Up Taiwan’s Protein Drugs Production
2022-06-05Partner
1 2 3 5
LATEST
Pfizer’s RSV Vaccine Gets FDA Approval for Use in Older Adults
2023-05-31
Brazil’s Evolving ESG Landscape from the Amazon to Atlantic Forest
2023-05-31
Should People Looking to Lose Weight Skip Sugar Substitutes?
2023-05-30
Advancing Next-Generation Cancer Metabolic Therapy by Targeting Critical Amino Acid Metabolic Pathways: An Interview with Brian A. Van Tine, MD, PhD
2023-05-26
Rona Therapeutics, Keymed Biosciences Team Up To Develop siRNA Drugs For Kidney Disease
2023-05-25
CDC Calls an End to J&J’s COVID-19 Vaccine in the U.S.
2023-05-25
A Close Look at the Evolution of ESG in Biopharma
2023-05-22
Scroll to Top